Salmerix (salmeterol, fluticasone) powder for inhalation dose 50 mcg/500 mcg/dose 60 doses in the inhaler

$50.00

Manufacturer: Lithuania

Purpose: Combines bronchodilator and corticosteroid to treat asthma by reducing inflammation and opening airways.

SKU: MED61140 Categories: , ,

Description

Salmerix (salmeterol, fluticasone) Powder for Inhalation Dose 50 mcg/500 mcg/dose 60 doses

Ingredients

Active ingredients: Each dose contains 50 mcg of salmeterol and 500 mcg of fluticasone.

Dosage

Dosage: The usual dose is 1 inhalation twice daily, approximately 12 hours apart.

Indications

Indications: Salmerix is indicated for the maintenance treatment of asthma in patients aged 4 years and older.

Contraindications

Contraindications: This medication is contraindicated in patients with severe hypersensitivity to salmeterol, fluticasone, or any of the excipients.

Directions

Directions: Before use, ensure proper inhaler technique. Inhale the medication as directed by your healthcare provider.

Scientific Evidence

Salmerix (salmeterol, fluticasone) has been extensively studied in clinical trials, demonstrating its efficacy in improving lung function and reducing asthma exacerbations. Research published in the Journal of Allergy and Clinical Immunology showed that the combination of salmeterol and fluticasone provided superior asthma control compared to either medication alone.

Furthermore, a meta-analysis published in the European Respiratory Journal concluded that the use of salmeterol and fluticasone together resulted in a significant reduction in the risk of severe asthma exacerbations compared to other standard treatments.

Additional Information

  • Pharmacological Effects: Salmeterol is a long-acting beta agonist that works by relaxing the muscles in the airways, while fluticasone is a corticosteroid that reduces inflammation in the lungs. The combination of these two medications provides both bronchodilation and anti-inflammatory effects.
  • Comparative Effectiveness: Compared to similar drugs, Salmerix has shown comparable or superior efficacy in controlling asthma symptoms and improving lung function. A study published in the Journal of Asthma reported that patients using salmeterol and fluticasone had fewer asthma exacerbations and better symptom control than those on other standard therapies.